Navigation Links
Ameritox Commends Operation UNITE on Its Inaugural National Rx Drug Abuse Summit
Date:4/6/2012

BALTIMORE, April 6, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, commends Unlawful Narcotics Investigations, Treatment and Education, Inc. (Operation UNITE), the organizers of the inaugural National Rx Drug Abuse Summit, on its coordination of a national forum to address the prescription drug abuse epidemic. The Summit will be held April 10-12 in Orlando, Florida.

"As the nation's leader in Pain Medication Monitoring Solutions®, Ameritox, like Operation UNITE, is committed to understanding the reasons behind the prescription drug abuse epidemic and working with state and Federal advocates toward a rapid and effective solution," said Dr. Harry Leider, Chief Medical Officer, Ameritox. "In our industry leadership role, Ameritox is charged with providing physicians who prescribe opioid therapy with effective tools, supported by quality research, to help ensure that proper medications are getting to the millions of chronic pain patients who need it.  In this way, we support physicians who treat patients with chronic pain and their efforts to reduce the misuse, abuse and diversion of prescription opioid medication."

Medication monitoring through urine drug testing is a critical tool in helping physicians provide the best care for patients receiving long term treatment with opioids. In February, Ameritox announced its support of a new set of expert consensus recommendations designed to bring uniformity to the use of pain medication monitoring and add specific recommendations to previous clinical guidelines. The recommendations also provided guidance on how to use urine drug monitoring to improve patient outcomes.

The leading service offered by Ameritox, Rx Guardian CD(SM), is a proprietary monitoring tool available to clinicians who prescribe opioids to patients with chronic pain aimed at helping to reduce the risk of opioid misuse, abuse and diversion. Rx Guardian CD consists of a reference database of more than 1,000 pain patients who were clinically assessed as adherent to their prescription regimens. It then displays the results in an innovative format, allowing physicians to see, at a glance, how a specific patient's results compare to patients in the database.

Ameritox recently launched the Rx Guardian INSIGHT(SM) Report, a tool developed with input from pain management physicians and designed to provide a concise summary of the most important elements of a patient's medication monitoring results. The report helps clinicians rapidly assess a patient's medication monitoring results over time by showing a chronology of previous Rx Guardian CD results.

"The number one cause of accidental death in the country is drug overdose, and prescription drug overdoses account for a significant number of these avoidable tragedies," Dr. Leider said. "The prescription drug abuse epidemic is the driving force behind the Ameritox commitment to work closely with physicians who prescribe these powerful medications.  We recognize that physicians are on the front lines of treating pain and reducing prescription drug misuse, abuse and diversion."

About Ameritox

Ameritox is the nation's leader in Pain Medication Monitoring Solutions®, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian(SM) – with Rx Guardian CD(SM), the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients assessed for medication adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through urine drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter@Ameritox, or on Facebook at facebook.com/ameritox.

© 2012 Ameritox Ltd. All rights reserved. AMERITOX, the AMERITOX logos, AMERITOX AUTOREMINDER, AMERITOX MEDICATION MONITORING SOLUTIONS, AMERITOX UNIVERSITY, PAIN MEDICATION MONITORING SOLUTIONS, POWERED BY YOUR NEED TO KNOW and PROTECT YOUR PATIENTS. PROTECT YOUR PRACTICE. RX GUARDIAN, RX GUARDIAN CD, and RX GUARDIAN AUTOREMINDER are trademarks of Ameritox.

For more information, contact:

Lon Wagner
Ameritox
Office: 336-387-7742
Lon.Wagner@ameritox.com

 


'/>"/>
SOURCE Ameritox
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
2. Ameritox® Continues to Advance Industry Leadership
3. Ameritox Supports Federal Implementation of Medication Monitoring for Chronic Pain Patients
4. Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion
5. Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
8. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
9. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
10. Lung Cancer Alliance Commends NCCN on Screening Guidelines
11. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Proliant Biologicals is ... Bovine Serum Albumin (BSA) manufacturing facility.  The facility is ... Zealand , in Feilding. Boone ... done to functionally duplicate the systems in the U.S. ... vendors used for U.S. installations.  --> ...
(Date:2/11/2016)... MEMPHIS, Tenn. , Feb. 11, 2016 ... a promising new treatment method at West Cancer ... low intensity electric fields to inhibit cancer cell replication ... therapy in more than a decade to show a ... adult Glioblastoma Multiforme (GBM) patients. Currently, West Cancer Center ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, ... Benefit Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. ... with Intel on value-based health benefits program Connected Care, will discuss the challenges ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... ... February 11, 2016 , ... Greenfield ... charity program created to assist the people of their local community. The agency ... organizations and community leaders. Their hope is to bring awareness to important local ...
(Date:2/11/2016)... FRANCISCO (PRWEB) , ... February 11, 2016 , ... ... Houston-based multi-specialty practice Village Family Practice , will be presenting at the ... 2016, in Las Vegas, Nev. , During his session, “ Coding for ...
(Date:2/11/2016)... , ... February 11, 2016 , ... The annual list ... on evaluation of DataPoint’s team dedication and commitment to the SharePoint ecosystem. ... the annual list. The panel’s goal is to recognize and promote technology entrepreneurship. ...
Breaking Medicine News(10 mins):